Cargando…
Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX
OBJECTIVE(S): Development of molecules that specifically recognize cancer cells is one of the major areas in cancer research. Human epidermal growth factor receptor 2 (HER2) is specifically expressed on the surface of breast cancer cells. HER2 is associated with an aggressive phenotype and poor prog...
Autores principales: | Moosavian, Seyedeh Alia, Jaafari, Mahmoud Reza, Taghdisi, Seyed Mohammad, Mosaffa, Fatemeh, Badiee, Ali, Abnous, Khalil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509953/ https://www.ncbi.nlm.nih.gov/pubmed/26221481 |
Ejemplares similares
-
Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer
por: Nourbakhsh, Mahnaz, et al.
Publicado: (2015) -
Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
por: Mashreghi, Mohammad, et al.
Publicado: (2020) -
Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX
por: Almasi, Faezeh, et al.
Publicado: (2016) -
Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers
por: Abdollahzade, Aref, et al.
Publicado: (2023) -
Nanocarriers Call the Last Shot
in the Treatment of Brain Cancers
por: Mehrabian, Amin, et al.
Publicado: (2022)